Axonin-1/TAG-1 is required for pathfinding of granule cell axons in the developing cerebellum by Baeriswyl, Thomas & Stoeckli, Esther T
BioMed  Central
Page 1 of 19
(page number not for citation purposes)
Neural Development
Open Access Research article
Axonin-1/TAG-1 is required for pathfinding of granule cell axons in 
the developing cerebellum
Thomas Baeriswyl and Esther T Stoeckli*
Address: Institute of Zoology, University of Zurich, Winterthurerstrasse, 8057 Zurich, Switzerland
Email: Thomas Baeriswyl - Thomas.Baeriswyl@zool.uzh.ch; Esther T Stoeckli* - Esther.Stoeckli@zool.uzh.ch
* Corresponding author    
Abstract
Background: Neural development consists of a series of steps, including neurogenesis, patterning,
cell migration, axon guidance, and finally, synaptogenesis. Because all these steps proceed in a
constantly changing environment, functional gene analyses during development have to take time
into account. This is quite challenging, however, as loss-of-function approaches based on classic
genetic tools do not allow for the precise temporal control that is required for developmental
studies. Gene silencing by RNA interference (RNAi) in combination with the chicken embryo or
with cultured embryos opens new possibilities for functional gene analysis in vivo. Axonin-1/TAG-
1 is a cell adhesion molecule of the immunoglobulin superfamily with a well defined temporal and
spatial expression pattern in the developing vertebrate nervous system. Axonin-1/TAG-1 was
shown to promote neurite outgrowth in vitro and to be required for commissural and sensory axon
pathfinding in vivo.
Results:  To knock down axonin-1 in a temporally and spatially controlled manner during
development of the nervous system, we have combined RNAi with the accessibility of the chicken
embryo even at late stages of development. Using ex ovo RNAi, we analyzed the function of axonin-
1/TAG-1 in cerebellar development. Axonin-1 is expressed in postmitotic granule cells while they
extend their processes, the parallel fibers. In the absence of axonin-1 these processes still extend
but no longer in a parallel manner to each other or to the pial surface of the cerebellum.
Conclusion: Axonin-1/TAG-1 is required for the navigation, but not for the elongation, of granule
cell processes in the developing cerebellum in vivo.
Background
Axonin-1 (AX-1)/TAG-1 is a cell adhesion molecule of the
immunoglobulin superfamily that was shown to be an
axon guidance cue in the central nervous system in vivo
[1,2]. Commissural axons in the spinal cord require AX-1
for midline crossing [3]. In the absence of interactions
between growth cone AX-1 and floor-plate NrCAM the
floor plate is perceived as repulsive and growth cones fail
to enter [4]. Sensory neurons from dorsal root ganglia
depend on AX-1 for subpopulation-specific navigation to
the gray matter of the spinal cord [5]. In the absence of
AX-1 function, nociceptive fibers failed to innervate their
target layers in the dorsal spinal cord and extended into
areas normally innervated by mechanoreceptive fibers. In
the cerebellum, AX-1 is expressed in postmitotic granule
cells at the time when they extend their processes, the par-
allel fibers [6-8].
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The cerebellum is responsible for motor coordination but
is also involved in cognitive processes [9,10]. Malforma-
tions or damage to the cerebellum have been linked to
several human disabilities, including ataxia, cerebral
palsy, and epilepsy [9]. In line with the more recent liter-
ature describing a contribution of the cerebellum to cog-
nitive processes, changes in cerebellar structure and
function have been linked to mental retardation, autism,
and schizophrenia [10]. The development of the cerebel-
lum has been studied in mouse [9,11-14] and in chicken
embryos [15-19]. Cells of the cerebellum originate from
rhombomere 1, the anterior-most part of the hindbrain
[19]. With one notable exception, the granule cells, all
cells are born in the ventricular zone and migrate radially
to reach their final destination in the mature cerebellum
[12,14]. The rhombic lip, the contact site between the roof
plate of the fourth ventricle and the neural tube, gives rise
to precursors of granule cells. These migrate tangentially
on the pial surface of the cerebellar anlage to form the
external germinal layer (EGL) [19-22]. After proliferation
in the outer EGL, granule cell precursors differentiate in
the inner EGL and extend their axons, the parallel fibers.
Together, parallel fibers and dendrites of Purkinje cells
form the molecular layer (ML). After the initial formation
of parallel fibers, granule cells migrate radially through
the Purkinje cell layer to form the inner granule cell layer
[12]. Thus, the only cell bodies that remain in the ML are
interneurons, stellate and basket cells that originate from
the ventricular zone [23,24]. Although these processes are
known at the cellular level, the molecular mechanisms
regulating these distinct steps are poorly understood.
To test for a role of AX-1 in parallel fiber extension in the
developing cerebellum, we used ex ovo RNA interference
(RNAi), a combination of RNAi and ex ovo culturing of
chicken embryos. In contrast to our previously established
method, in ovo RNAi [25], ex ovo RNAi enhances the acces-
sibility of chicken embryos for loss-of-function
approaches at late stages of development.
We developed in ovo RNAi as a tool to study gene function
in a temporally controlled manner during development of
the chicken nervous system [25-27]. Using this technique,
we demonstrated, for instance, additional functions of the
morphogen Sonic hedgehog (Shh) beyond patterning and
differentiation [28]. During early stages of development,
Shh acts as a ventralizing factor in spinal cord patterning
[29]. Later, still using Patched and Smoothened to medi-
ate its effect, Shh attracts commissural axons toward the
floor plate [30]. Only a few hours later, Shh switches
receptors and, mediated by Hip (Hedgehog-interacting
protein), acts as a guidance cue for postcommissural
axons [31]. The analysis of Shh's function clearly demon-
strates the importance of tight temporal control of gene
silencing during embryonic development [26,27].
Ex ovo RNAi extends the usefulness of the chicken embryo
as a model organism to study later stages of neural devel-
opment during which the embryo is no longer easily
accessible in the egg. Chicken embryos can be transferred
from the egg to a plastic dish without detrimental effects
on their development. The absence of the eggshell
enhances access to the developing embryo for experimen-
tal manipulation. Ex ovo RNAi allowed us to study the role
of AX-1 in parallel fiber formation. In the absence of AX-
1 function, neurites of granule cells still extended but
failed to navigate correctly in the developing ML. Rather
than extending in a parallel manner, they invaded the
layer of proliferating granule cells at the pial surface of the
cerebellum.
Results
Embryos grown ex ovo can easily be accessed for 
manipulation of gene expression in a temporally and 
spatially controlled manner
To enhance its accessibility during later stages of develop-
ment, the chicken embryo can be cultured in a dish with-
out adverse effects on development [32-35]. To have
access to the developing cerebellum, we transferred
embryos to a domed dish after the second day of incuba-
tion (Additional file 1). As described previously [35], the
transfer should be done no later than embryonic day 2.5
(E2.5) for best survival of the embryo. The survival rate of
embryos depended on several factors, including tempera-
ture and humidity in the incubator, as well as the time of
embryo transfer. Routinely, we found 62% of the embryos
alive on E8, the time of injection in this study. At that
time, embryos grown in a dish did not differ from
embryos kept in the egg. Similarly, the comparison of cer-
ebellar development between embryos developing in the
egg and those developing in a dish for up to ten days after
transfer (the latest time point that we analyzed) revealed
no differences (Additional file 2).
Injections into the cerebellum had to be carried out with-
out direct visual control. However, the blood vessels that
are readily visible through the skin could be used as land-
marks (Figure 1a). By using an expression plasmid encod-
ing enhanced green fluorescent protein (EGFP), the
proper injection site, the required depth of the injection,
as well as the best electroporation settings were deter-
mined. For electroporations we placed the head of the
embryo between tweezer electrodes. To prevent tissue
damage, direct contact between embryo and electrodes
was carefully avoided (Figure 1b). The cerebellum was
efficiently transfected with 6 pulses of 99 ms duration at
40 V, as judged by the number of EGFP-expressing cells
(Figure 1d–i). Only one half of the cerebellum expressed
the transgene, because the negatively charged nucleic
acids were migrating towards the anode (Figure 1c,d).
Therefore, the untransfected side of the cerebellum couldNeural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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be used as a control for the analysis of potential pheno-
types. When injections were carried out at Hamburger and
Hamilton stage 34 (HH34; E8) [36], the survival rate one
day after the experiment was 72%. However, the time
point of the injection is not restricted to HH34. Injections
and electroporations were performed successfully until
HH36 (E10; not shown).
Depending on the depth of the injection, different cere-
bellar layers could be targeted. Injections into the ventri-
cle resulted in transfection of the ventricular zone, the
origin of Purkinje cells and interneurons (Figure 1e). After
superficial injections into the cerebellar anlage, cells of the
developing ML (Figure 1f,g) and granule cells in the EGL
were transfected (Figure 1h,i), similar to observations
made in postnatal rat pups [37]. To get efficient transfec-
tion of all cerebellar layers, the glass capillary was inserted
into the ventricle and the injection pressure was main-
tained during its retraction. For this study, we used only
sections that were successfully transfected in the EGL and
the developing ML. For analyses of experimental and con-
trol embryos, we carefully matched cerebellar sections
with respect to their anteroposterior and mediolateral
positions.
Ex ovo RNAi does not induce apoptosis or morphological 
changes
To make sure that injection and subsequent electropora-
tion of plasmids encoding EGFP or of long double-
stranded RNA (dsRNA) into the cerebellum did not
Different cerebellar layers can be targeted by ex ovo electroporation Figure 1
Different cerebellar layers can be targeted by ex ovo electroporation. The cerebellar anlage is positioned right under 
the bifurcation of the middorsal sinus and the middle cerebral vein. (a) The injection site is indicated by +. The head of the 
embryo was turned and stabilized with a hook prepared from a spatula (arrowhead). (b) Tweezer electrodes were placed par-
allel to the head. It was important to avoid contact between embryo and electrode (indicated by white brackets) to prevent tis-
sue damage. (c,d) One half of the cerebellum was successfully transfected by electroporation. The untransfected half of the 
cerebellum could serve as an internal control for the analysis of phenotypes. (d) Successful transfection of one half of the cere-
bellum after ex ovo electroporation with platelet electrodes is shown in a 250-µm-thick coronal slice. (e-i) Depending on the 
depth of the injection, different cerebellar layers could be targeted: deep injections into the ventricle resulted predominantly in 
transfection of the ventricular zone labeling all cell types proliferating and migrating from there, such as Purkinje cells, interneu-
rons, and glia cells (e). With superficial injections the developing ML (f,g) and granule cells of the external germinal layer (h,i) 
were transfected. Parallel fibers in the developing ML were visualized using AX-1 as a marker (g). Granule cells were identified 
by Pax6 (i). EGL, external germinal layer; ML, molecular layer; PS, pial surface; V, ventricle. Bar: 2 mm in (a,b), 1 mm in (c), 500 
µm in (d), 100 µm in (e-g), 50 µm in (h,i).Neural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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Ex ovo electroporation and RNAi using long dsRNA does not induce apoptosis and does not disturb cerebellar organization Figure 2
Ex ovo electroporation and RNAi using long dsRNA does not induce apoptosis and does not disturb cerebellar 
organization.(a-c) Apoptosis was investigated by TUNEL in 30-µm-thick sagittal sections at HH35, one day after electropo-
ration. Corresponding areas are shown in (a-c). No difference in apoptosis was detected between untreated embryos (a), 
embryos injected with EGFP plasmids alone (b), and embryos injected with AX-1 dsRNA (c). (d-f) The organization and the 
development of Purkinje cells analyzed by Calbindin staining at HH38 did not differ between untreated control embryos (d), 
EGFP-expressing control embryos (e), and embryos electroporated with AX-1 dsRNA (f). (g-i) Similarly, no changes in Berg-
mann glia cells were detectable at HH37 after staining for Vimentin, when untreated (g), EGFP-expressing control embryos (h), 
and embryos lacking AX-1 (i) were compared. Bar: 100 µm in (a-c), 200 µm in (d-f), and 50 µm in (g-i).Neural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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induce non-specific effects, we checked for apoptosis and
histological changes in the transfected area of the cerebel-
lum (Figure 2). Apoptosis was compared between
untreated control embryos (Figure 2a), control embryos
injected and electroporated with the EGFP plasmid alone
(Figure 2b), and experimental embryos injected and elec-
troporated with EGFP and dsRNA derived from AX-1 (Fig-
ure 2c). We did not find any difference in apoptosis
between control and experimental embryos, indicating
that our experimental procedure did not induce cell
death. This is consistent with our previous findings dem-
onstrating that injection and electroporation of long
dsRNA did not induce unspecific effects in the chicken
spinal cord [25].
The comparison of sections from control-injected/electro-
porated and untreated control embryos stained with
methylene blue confirmed the absence of morphological
changes in experimental embryos (not shown). The cere-
bellar foliation and the organization of the EGL were
unchanged three days after electroporation. Furthermore,
the organization of Purkinje cells and Bergmann glia cells
was visualized by staining for Calbindin (HH38; Figure
2d–f) and Vimentin (HH37; Figure 2g–i), respectively. No
changes were observed when experimental embryos were
compared with control embryos three and four days after
electroporation, respectively. Taken together, we did not
find any evidence that ex ovo RNAi induced apoptosis,
morphological changes, or developmental delays during
cerebellar development.
Ex ovo RNAi effectively silences the targeted gene
AX-1 is expressed in postmitotic granule cells in the EGL
of the developing cerebellum ([6-8]; this study). To dem-
onstrate efficient downregulation of AX-1 in these cells by
ex ovo RNAi, we mixed dsRNA derived from AX-1 with a
plasmid encoding EGFP at a molecular ratio of 50:1. In all
experiments EGFP expression was used to identify the
position and the size of the electroporated area in the cer-
ebellum. Electroporation of AX-1 dsRNA efficiently
knocked down AX-1 protein (Figure 3). Caudal cerebellar
sections taken from an experimental embryo exhibited a
patchy pattern of AX-1 expression (Figure 3b) in contrast
to the homogenous appearance in a control embryo (Fig-
ure 3d). As expected, the vast majority of EGFP-expressing
cells did not express AX-1 (Figure 3c). Consistent with the
50-fold excess of dsRNA molecules compared to the EGFP
plasmid, we found many cells that no longer expressed
AX-1 but failed to express EGFP.
For the quantification of gene silencing we calculated the
relative intensity of AX-1 staining in the electroporated
area (Figure 3f) compared to the corresponding non-tar-
geted area of the cerebellum (Figure 3g). A strong decrease
of more than 60% of the AX-1 staining intensity was seen
in the electroporated area of the cerebellum (identified by
EGFP expression; Figure 3e) when embryos were injected
and electroporated with AX-1 dsRNA (Figure 3i). As
expected, there was no downregulation of AX-1 in the
transfected area of embryos injected with the EGFP plas-
mid alone (Figure 3h,i).
In order to demonstrate the specificity of ex ovo RNAi, we
monitored the expression of the related cell adhesion
molecules NgCAM, NrCAM, and Contactin/F11 that are
expressed in the developing chicken cerebellum (Figure
4). In agreement with published reports, we found that
AX-1 preceded NgCAM, NrCAM, and Contactin/F11
expression in postmitotic granule cells [38-40]. After
downregulation of AX-1 no changes in the expression of
NgCAM, NrCAM, and Contactin/F11 were observed (Fig-
ure 5). Taken together, these results indicate that ex ovo
RNAi with long dsRNA derived from AX-1 effectively
knocked down AX-1 levels without affecting non-targeted
but related genes expressed in the cerebellum.
Downregulation of AX-1 by ex ovo RNAi results in 
aberrant extension of parallel fibers
For functional analysis of AX-1 in the developing cerebel-
lum, we injected two long dsRNA fragments that were
used previously to analyze the function of AX-1 in com-
missural axon guidance by in ovo RNAi [25]. Injection of
either one of the dsRNAs derived from AX-1 resulted in
the same respective phenotypes in the spinal cord and in
the cerebellum. In the spinal cord, loss of AX-1 caused the
failure of commissural axons to cross the midline
[3,4,25]. Knock down of AX-1 in the developing cerebel-
lum at HH34 resulted in the failure of granule cell axons
to extend parallel to each other and parallel to the pial sur-
face (Figure 6). When analyzed in coronal slices at HH35,
parallel fibers were found to deviate from their normal
trajectory, often even invading the outermost part of the
EGL, where granule cell precursors proliferate (Figure
6c,f). In control embryos injected with dsRNA derived
from CD34, a gene not expressed in the cerebellum, or in
control embryos injected with the EGFP plasmid alone
(Figure 6e), neurofilament staining was not found in the
outer EGL. The same was true for the contralateral side of
experimental embryos (Figure 6d). The failure of granule
cell axons to extend in a parallel manner with respect to
each other and with respect to the pial surface was
reflected in the irregular appearance of the ML (Figure 6b).
Its width was non-uniform and the fiber density appeared
strongly reduced. Because we did not observe an increase
in cell death compared to control embryos (Figure 2) we
took the apparent decrease in fiber number in the devel-
oping ML as further evidence for the aberrant growth of
parallel fibers. Because it was impossible to count the
number of aberrant fibers individually, we measured the
intensity of neurofilament staining in the developing ML.Neural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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As the width of the layer varies considerably depending on
the anteroposterior position in the cerebellum, we meas-
ured the staining intensity as a ratio between the targeted
and the contralateral side. The comparison of neurofila-
ment staining intensity between the experimental and the
control sides indicated a 38% decrease in AX-1 dsRNA-
treated embryos (n = 19 slices from 9 embryos) but no
changes in EGFP-treated embryos (n = 14 slices from 6
Gene silencing by ex ovo RNAi is efficient Figure 3
Gene silencing by ex ovo RNAi is efficient. The efficiency of AX-1 downregulation was demonstrated in caudal sections 
taken from HH35 cerebella one day after injection and electroporation of dsRNA derived from AX-1 mixed with a plasmid 
encoding EGFP (50:1). (a) EGFP expression was used to identify the electroporated area of the cerebellum. (b,c) Expression 
of AX-1 was lost from many cells after ex ovo RNAi, resulting in a patchy appearance of the granule cell layer (b; c, open 
arrows). (d) In corresponding sections of a control embryo AX-1 staining appeared homogenous. (c) The number of EGFP-
expressing cells (white arrows) was much smaller than the number of cells that failed to express AX-1 due to the molecular 
ratio of 50:1 for dsRNA and EGFP plasmid. Very few cells were yellow, indicating both EGFP and AX-1 expression (c, arrow-
head). For quantitative analysis, 30-µm-thick sagittal sections were stained for AX-1. (e) EGFP expression was used to identify 
the electroporated area of the cerebellum. Staining intensities were compared between experimental (e,f) and control (EGFP) 
embryos (h) at HH35, one day after electroporation. (f,i) On average, the injection and electroporation of AX-1 dsRNA 
reduced the AX-1 protein level in the transfected area by 61.3 ± 9.4% (n = 4 embryos; ***P < 0.0001 for comparison with both 
control groups). (g) As expected, there was no change in AX-1 protein levels in the untransfected part of the cerebellum of 
embryos treated with dsRNA. (h,i) AX-1 expression in transfected areas of embryos treated with the EGFP plasmid alone did 
not differ from untreated control embryos (not shown; i). The ratio of AX-1 staining was 3.4 ± 2.2% (n = 5) for EGFP-control 
embryos and 2.3 ± 0.9% (n = 4) in untreated control embryos. The insert in (e) shows a low magnification image of the section. 
The box corresponds to the high magnification image shown in (e). PS, pial surface. Bar: 50 µm in (a-d), 200 µm in (e-h).Neural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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AX-1 expression in postmitotic granule cells precedes expression of NgCAM, NrCAM, and Contactin/F11 Figure 4
AX-1 expression in postmitotic granule cells precedes expression of NgCAM, NrCAM, and Contactin/
F11.(a,d,g,j,m) AX-1 is a marker for postmitotic granule cells that start to extend processes in the inner EGL [6,8]. (a-c) 
Double-staining of sagittal sections taken from HH35 brains demonstrated that AX-1 (a) labeled young postmitotic granule 
cells in the inner EGL (iEGL) that were not yet NgCAM-positive (b; merged in c). Therefore, an overlap between AX-1 and 
NgCAM was only found in the ML, where older granule cells are located (c). (d-f) Double staining for AX-1 (d) and NrCAM 
(e) revealed that there was less overlap between AX-1 and NrCAM (f) compared to AX-1 and NgCAM (c). (g-i) Similarly, 
there was little overlap (i) between AX-1 (g) and Contactin/F11 (h), consistent with previous reports [39]. (j-l) AX-1 is 
expressed in postmitotic granule cells but not in granule cell precursors in the outer EGL (oEGL) that are still proliferating (j). 
Precursors and postmitotic granule cells are identified by Pax6 staining (k) [42]. The overlap between AX-1 and Pax6 is 
restricted to the inner EGL (l). (m-o) AX-1 reactivity (m) mostly overlapped with RMO270 reactivity (n), demonstrating that 
the vast majority of the neurofilament signal at HH35 was generated by granule cells (o). Bar: 50 µm.Neural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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Downregulation of AX-1 does not change the expression of related cell adhesion molecules Figure 5
Downregulation of AX-1 does not change the expression of related cell adhesion molecules. We compared 
expression of related immunoglobulin superfamily cell adhesion molecules between (a,c,e) embryos lacking AX-1 and (b,d,f) 
age-matched untreated control embryos at HH35, one day after ex ovo RNAi. We found no changes in NgCAM (a,b), NrCAM 
(c,d), and Contactin/F11 expression (e,f). Inserts in (a,c,e) show adjacent sections stained for EGFP to demonstrate that sec-
tions were taken from the electroporated area of the cerebellum. Bar: 100 µm in (a-d), 50 µm in (e,f).Neural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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Silencing AX-1 in the developing cerebellum induces aberrant trajectories of parallel fibers Figure 6
Silencing AX-1 in the developing cerebellum induces aberrant trajectories of parallel fibers.(a-c,f) Parallel fibers 
from areas outlined in (a) were analyzed in 250-µm-thick vibratome slices taken from HH35 cerebella after downregulation of 
AX-1 by ex ovo RNAi at HH34 (a-c,f). (b) In the absence of AX-1, the formation of the ML was severely disturbed in the trans-
fected area. The width of the ML was irregular and fiber density was clearly reduced (arrows). (c) Most strikingly, axons of 
granule cells failed to extend in a parallel manner both with respect to each other and with respect to the pial surface (open 
arrows). (f) The same phenotype was obtained with a different long dsRNA derived from the AX-1 cDNA (open arrows). (d) 
On the contralateral side of the cerebellum injected and electroporated with AX-1 dsRNA the organization of the ML and the 
density of the parallel fibers were indistinguishable from non-injected, age-matched control embryos. (e) As expected, no dif-
ference between non-injected (not shown) and EGFP-injected control embryos was observed. (g,h) As an independent 
method for AX-1 perturbation, we used antibodies to block AX-1 function at the protein level. The phenotype obtained by ex 
ovo RNAi was reproduced with function-blocking antibodies. (i) The effect of AX-1 silencing by ex ovo RNAi was quantified. 
The relative fluorescence intensity after neurofilament staining was determined as a measure for the decrease in both ML 
width and parallel fiber density. On average, the staining intensity of the ML on the targeted side, that is, in the absence of AX-
1, was reduced by 37.8 ± 3.6% compared to the non-affected control side (AX-1 dsRNA; n = 19 slices from 9 embryos). The 
staining intensities did not differ between the two halves of the cerebellum in embryos electroporated with the EGFP plasmid 
alone (EGFP; -0.3 ± 2.8%; n = 14 slices from 6 embryos) or in non-treated control embryos (control; 1.1 ± 3.2%; n = 10 slices 
from 4 embryos). ***P-values were < 0.0001 for the comparison between embryos treated with AX-1 dsRNA and EGFP-
expressing control embryos, and experimental embryos versus non-treated control embryos. PS, pial surface; V, ventricle. Bar: 
500 µm in (a), 100 µm in (b,d,e,g), and 50 µm in (c,f,h).Neural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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embryos) or untreated embryos (n = 10 slices from 4
embryos) (Figure 6i).
These results were reproduced qualitatively in embryos
treated with function-blocking anti-AX-1 antibodies (Fig-
ure 6g,h). Thus, perturbation of AX-1 function either by ex
ovo RNAi or by injection of function-blocking antibodies
resulted in aberrant growth of granule cell axons.
Knock down of AX-1 interferes with guidance but not 
growth of parallel fibers
Loss of AX-1 in vivo did not prevent the formation of gran-
ule cell axons, but interfered with their orientation (Figure
7). Previous in vitro studies did not detect an effect of TAG-
1/AX-1 on mouse granule cell axon extension [41]. Con-
sistent with these results, we found that blocking AX-1
function in vivo did not interfere with axon extension but
with the direction of their growth. The comparison of
granule cells in slices taken from control-injected embryos
and embryos lacking AX-1 at high magnification revealed
normal T-shaped axons in controls at HH35 (Figure 7a)
but aberrant growth of axons toward the pial surface in
experimental embryos (Figure 7b,c).
The aberrant growth of fibers is not caused by changes in 
granule cell development and maturation
To rule out an effect of aberrant granule cell development
on parallel fiber formation, we analyzed the migration of
granule cells from the EGL through the developing ML.
For this purpose we used Pax6 as a marker for granule cell
somas [42] at HH35 (Figure 8a,b) and HH38 (Figure
8c,d). Downregulation of AX-1 did not interfere with
granule cell migration (Figure 8b,d) compared to
untreated controls (Figure 8a,c). Furthermore, the lack of
AX-1 did not interfere with granule cell maturation. In
particular, the number and position of proliferating gran-
ule cell precursors in the outer EGL was indistinguishable
between control embryos (Figure 8e) and experimental
embryos (Figure 8f). Thus, lack of AX-1 did not interfere
with granule cell proliferation and migration.
AX-1 is required for parallel fiber formation but not for 
neurite extension in vitro
To address the mechanism underlying the observed fail-
ure of granule cell axons to extend in a parallel manner to
each other and to the pial surface, we investigated the role
of AX-1 in neurite outgrowth promotion in vitro. When
Guidance but not growth of granule cell axons is affected in the absence of AX-1 in vivo Figure 7
Guidance but not growth of granule cell axons is affected in the absence of AX-1 in vivo.(a) Detailed analyses of 
coronal slices taken from control-injected embryos at HH35 revealed correctly formed parallel fibers expressing EGFP 
(arrows). (b,c) In contrast, EGFP-expressing granule cells in embryos injected and electroporated with AX-1 dsRNA and the 
EGFP plasmid did not extend their axons parallel to, but rather towards, the pial surface (open arrows). (c) Overlay with a neu-
rofilament staining outlines non-electroporated parallel fibers in the developing ML. Bar: 25 µm.Neural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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Downregulation of AX-1 does not interfere with granule cell development or migration Figure 8
Downregulation of AX-1 does not interfere with granule cell development or migration. Perturbation of AX-1 
expression did not interfere with granule cell migration from the EGL through the ML. (a-d) No change in the distribution of 
Pax6-positive granule cells was detectable between untreated control embryos at HH35 (a) or HH38 (c) and embryos injected 
and electroporated with dsRNA derived from AX-1 at HH35 (b) or HH38 (d). (e,f) As expected, downregulation of AX-1 by 
ex ovo RNAi at HH34 did not interfere with proliferation of granule cell precursors, as AX-1 is expressed only after granule 
cells become postmitotic. Sagittal sections labeled with BrdU and counterstained with DAPI taken from control embryos (e) 
and embryos lacking AX-1 (f) at HH38 did not differ. Inserts in (b,d,f) show adjacent sections stained for EGFP to demonstrate 
that sections were taken from the electroporated area of the cerebellum. Bar: 50 µm.Neural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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laminin was used as a substrate, granule cell axons grew
almost exclusively on or in close contact with glia cells.
Blocking AX-1 function did not interfere with this behav-
ior nor change neurite length (Figure 9). Neurite length
was 101.0 ± 7.3 µm for granule cells grown without anti-
bodies added to the medium, 101 ± 9.7 µm in the pres-
ence of non-immune goat IgG, and 94.5 ± 7.6 µm in the
presence of goat anti-AX-1 IgG.
Further confirmation for the absence of an effect of AX-1
on granule cell axon outgrowth was found when we
coated culture dishes with purified AX-1. As described ear-
lier [43,44], AX-1 supported axon outgrowth and the for-
mation of characteristic, large growth cones from dorsal
root ganglion neurons. However, under the same condi-
tions, we did not detect neurite outgrowth from granule
cells (Figure 10), confirming previous results obtained
with mouse granule cells and TAG-1 [41]. In agreement
with our previous observations of granule cells cultured in
the presence of function-blocking antibodies (Figure 9),
they extended neurites on laminin, no matter whether
they expressed AX-1 or not, that is, when AX-1 was down-
regulated by in vitro electroporation before plating (Figure
10g–l). In contrast, no axons were found on AX-1 used as
a substrate (Figure 10a–f). Therefore, we concluded that
AX-1 was required for axon guidance but not for axon
growth, in agreement with earlier observations made for
commissural neurons from the dorsolateral spinal cord
[45].
Discussion
The chicken embryo was rediscovered as a modern model
organism for developmental studies due to the use of elec-
troporation for efficient gene transfer in vivo [33,35,46-48]
(reviewed in [26,27]). With this method, gain-of-function
studies by spatially and temporally controlled expression
of a target gene became possible [33,49-53]. However,
loss-of-function phenotypes still depended on the availa-
bility of dominant-negative forms of candidate proteins.
Therefore, the combination of in ovo electroporation and
RNAi that allowed for temporally and spatially controlled
gene silencing was an important step forward [25,31,54].
Functional studies by in ovo RNAi using long dsRNA, short
interfering RNAs, or short hairpin RNAs have been carried
out in various parts of the central nervous system but also
in other embryonic tissues [25,31,54-57]. At later stages of
development, the accessibility of the growing embryo
through the small window in the eggshell is restricted and,
therefore, the time window for in ovo electroporation
closes at around E5.
In this study, we show that ex ovo electroporation and
RNAi can be used for functional gene analysis at late
developmental stages in the developing cerebellum. In the
chick, the formation of the distinct cerebellar layers starts
AX-1 is not required for neurite extension on laminin Figure 9
AX-1 is not required for neurite extension on lam-
inin.(a-i) Granule cells were plated on laminin in the 
absence of antibodies (AB) (a-c), in the presence of non-
immune antibodies (d-f), and in the presence of goat anti-AX-
1 antibodies (g-i). Neurites were stained with a rabbit anti-
neurofilament (NF) antibody (a,d,g). Granule cells were iden-
tified by Pax6 (b,e,h). Merged images are shown in (c,f,i). 
Neurite morphologies and lengths did not differ under these 
conditions. Values were 101.0 ± 7.3 µm (n = 27) in the 
absence of antibodies, 101.1 ± 9.7 µm (n = 23) in the pres-
ence of non-immune, and 94.5 ± 7.6 µm (n = 31) in the pres-
ence of anti-AX-1 antibodies. Bar: 25 µm.Neural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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AX-1 does not promote outgrowth of granule cell axons Figure 10
AX-1 does not promote outgrowth of granule cell axons.(a-f) When granule cells were cultured on AX-1 as a sub-
strate they failed to extend neurites, no matter whether they expressed AX-1 (a-c) or not (d-f). Granule cells were electropo-
rated with dsRNA derived from AX-1 and the EGFP plasmid in vitro, before they were cultured on AX-1 substratum (d-f) and 
compared with cells electroporated with the EGFP plasmid only (a-c). (g-l) On laminin substratum, both granule cells express-
ing AX-1 (g-i) and those lacking AX-1 (j-l) extended axons. Granule cells were identified by Pax6 expression (a,d,g,j). Electro-
porated cells expressed EGFP (b,e,h,k). Merged images are shown in (c,f,i,l). Asterisks indicate electroporated granule cells 
identified by EGFP and Pax6 expression. Open arrows label axons from Pax6-positive neurons that also express EGFP. Bars: 25 
µm in (a-f) and 50 µm in (g-l).Neural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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around HH34 (E8). The cerebellum represents an ideal
system to investigate the multiple processes contributing
to central nervous system development, including cell
proliferation [58], differentiation [59], migration [60,61],
axon growth and guidance [40], as well as synaptogenesis
[62].
Luo and Redies [33] demonstrated that ex ovo electropora-
tion can be used to transfect Purkinje cells. Using a tung-
sten needle as cathode, Purkinje cell progenitors were
successfully electroporated after injection of a GFP plas-
mid into the ventricular system at E3.5. However, tempo-
rally and spatially controlled transfection of different
cerebellar cell types was not possible at these early stages
[33,35]. Furthermore, electroporation of antisense cDNA
to induce a loss-of-function phenotype at E3.5 was not
sufficient for functional readouts at later stages of cerebel-
lar development (E11.5) [63]. Due to ongoing cell prolif-
eration, transfected antisense cDNAs were diluted
extensively, resulting in inefficient downregulation of the
target gene. An additional problem with the early electro-
poration of antisense nucleotides, but also dsRNA for
RNAi, may occur if a candidate gene exerts multiple func-
tions at different stages of development. Early disruption
of gene function would prevent any further functional
analysis at later developmental stages. Therefore, our
focus was to design appropriate conditions to extend the
applicability of RNAi to older stages of embryonic devel-
opment. With this protocol, AX-1 in granule cells of the
EGL could efficiently be downregulated (Figure 3).
Despite the fact that some genes involved in cerebellar
specification have been identified [13], the molecular
basis of cerebellar development is still poorly understood
[9,64]. A number of cell adhesion molecules of the immu-
noglobulin superfamily are expressed in granule cells,
including NgCAM/L1 [38], NrCAM [38], Contactin/F11/
F3 [40,65], and AX-1/TAG-1 [6-8]. In vitro studies indi-
cated an inhibitory role of Contactin/F3 in parallel fiber
outgrowth [66]. In vivo, parallel fibers extended in the
absence of Contactin/F3 but their growth and contact
with dendrites of Purkinje cells was aberrant [40]. Only
later extending parallel fibers were affected in contactin/
F3 knockout mice, growth of early extending fibers was
normal, consistent with the late onset of contactin/F3
expression in granule cells compared to TAG-1/AX-1
[8,39]. A forced early expression of Contactin/F3 under
the TAG-1 promoter interfered with the correct formation
of the ML [39]. Reduced cerebellar size and defects in foli-
ation were found in mice lacking both L1/NgCAM and
NrCAM [38]. The defect was the result of a lack of granule
cell survival rather than an effect on parallel fiber growth.
Only very subtle cerebellar phenotypes were found in
mice lacking only one of the two genes [38]. Mice lacking
TAG-1 were shown to have a migration defect of a subset
of pre-cerebellar neurons in the superficial migratory
stream, but no cerebellar phenotype was reported in these
mice [67,68]. The absence of an effect on granule cells was
unexpected based on the expression of TAG-1/AX-1 in
postmitotic granule cells at the time of parallel fiber exten-
sion [68]. Similarly, no effect on commissural axons was
found in the spinal cord of the Tag-1 knockout mouse
[68], in contrast to the chicken embryo where the pertur-
bation of AX-1 function resulted in the failure of commis-
sural axons to cross the midline [3,25]. The most likely
explanation for this discrepancy is the technique used to
block TAG-1/AX-1 function. While TAG-1 is permanently
and ubiquitously deleted in the knock-out mouse, AX-1
function was blocked acutely during a specific time win-
dow of interest in our ex ovo RNAi approach ([25]; this
study) or by the injection of function-blocking antibodies
[3,4]. Therefore, redundancy or compensatory mecha-
nisms that are generally thought to explain the absence of
phenotypes in knock-out mice [38,67,68] would not be
present in the 'acute' knock down of AX-1 in chicken
embryos. Such a scenario would also explain the discrep-
ancy between the NrCAM knockout mouse [69] and our
previous reports on the effect of acute perturbation of
NrCAM function by injection of function-blocking anti-
bodies [3,5] and in ovo RNAi [25] on axon guidance in the
spinal cord. Thus, despite the fact that acute knock down
of a gene of interest by RNAi is not removing all of the
gene product, because preexisting protein is not removed
and only a subset of the cells in the target area are trans-
fected by electroporation, this approach may be more sen-
sitive for the analysis of gene function during embryonic
development compared to generic knock-out approaches
that are the method of choice when gene function in the
adult nervous system is of interest.
Downregulation of AX-1 in the developing cerebellum by
ex ovo RNAi specifically interfered with the formation of
parallel fibers. This defect was not caused by inhibition of
axon extension, as we found no effect of AX-1 on neurite
length  in vitro. Furthermore, our analyses of cerebellar
slices taken from embryos lacking AX-1 are consistent
with an effect of AX-1 on guidance but not on growth of
granule cell axons. Granule cells still extended axons after
downregulation of AX-1, although their orientation was
aberrant (Figure 7).
These results are consistent with earlier observations
made with commissural neurons from the dorsolateral
spinal cord in vitro and in vivo [3,45]. AX-1 was required
for the choice of commissural axons between different
substrates that supported axon extension, but had no
effect on axon growth in vitro. The same conclusion was
drawn from in vivo studies where the absence of AX-1
resulted in the failure of commissural axons to cross the
midline but did not affect neurite extension that wasNeural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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shown to depend on NgCAM and NrCAM. The effect of
AX-1 on granule cell axon guidance is most likely due to a
homophilic AX-1/AX-1 interaction [70,71], as the granule
cells that extend axons early do not express any of the
known binding partners of AX-1, such as NgCAM (Figure
4b), NrCAM (Figure 4e), or Contactin/F11 (Figure 4h;
[39]). Expression of those molecules is found only in
older parallel fibers in the developing ML. Furthermore, a
homophilic interaction of AX-1 is consistent with all our
in vitro and in vivo results.
Conclusion
AX-1 is expressed by granule cells as soon as they become
postmitotic and is required for the parallel arrangement of
their axons but is not required for neurite extension. This
is similar to the situation found for commissural axons of
the spinal cord. They require AX-1 for pathfinding but not
for elongation. In contrast, AX-1 was found to be required
for guidance of sensory DRG axons in vivo [5] and to pro-
mote their outgrowth in vitro [43,44]. Taken together,
these results demonstrate that AX-1 acts in a context-
dependent manner either as an axon guidance cue with-
out affecting neurite outgrowth, or as a molecule promot-
ing neurite outgrowth. In the cerebellum, AX-1 expressed
by postmitotic granule cells is required for the navigation
of parallel fibers in the developing ML.
Materials and Methods
Ex ovo culture for chicken embryos
Fertilized Hisex eggs were obtained from a local hatchery
and pre-incubated for 2.5 days at 38.5°C with a humidity
of at least 45%. After the egg had been positioned on the
side for at least 20 minutes to allow for the embryo to
float on top of the yolk, it was wiped with 70% ethanol,
and cracked on a sharp edge. The whole egg content was
transferred carefully into a domed dish with a diameter of
80 mm and a depth of 40 mm. These dishes were pro-
duced for the food industry from oriented polystyrene
(OPS; Bellaplast, Altstaetten, Switzerland; Additional file
1). To minimize evaporation, the dish was covered with a
lid. The ex ovo cultures were kept in an egg incubator at
38.5°C (Heraeus B12, Therrmo Fisher Scientific, Wohlen,
Switzerland). To evaluate the survival rate at different
stages of development, we opened the incubator once a
day to count survivors (Additional file 1d). However, for
routine experiments and best survival rate the incubator
was not opened for the first 6 days of ex ovo culturing.
Under these conditions the survival rate was much better
(on average 62% at E8). Compared to the ex ovo culturing
method described by Luo and Redies [35], the use of a
domed dish was advantageous. We had better survival for
a longer period of time in the domed polystyrene dishes.
Contaminations were very rare (much less than 1%),
although we did not work in a laminar flow hood.
Synthesis of dsRNA
For in vitro transcription, 2 µg of the linearized (cut with
BamHI and SacI; Roche, Basel, Switzerland) and purified
plasmids encoding AX-1 (either nucleotides 28–1,592 or
nucleotides 1,620–2,298 of the full-length cDNA; see [25]
for details) were mixed with 0.8 µl 100 mM rNTPs (25
mM each; Roche), 0.5 µl RNasin (Promega, Duebendorf,
Switzerland), 2 µl Sp6 or T7 RNA polymerase (15 U/µl;
Promega), and 2 µl 100 mM DTT in transcription buffer
(final volume 20 µl). After 4 h at 37°C, the DNA template
was removed from the in vitro transcription mixture by
digestion with 20 units RNase-free DNaseI (Roche) for 1
h at 37°C. For dsRNA derived from CD34, nucleotides
1,640–2,417 of the full-length cDNA (XM_417984) were
used. The plasmid was linearized with NotI (New England
Biolabs, Ipswich, MA, USA) and EcoRI (Roche) and single-
stranded RNA (ssRNA) was prepared using T3 and T7 RNA
polymerases. The synthesized ssRNA was purified by
sequential extraction with acidic phenol-chloroform
(25:24:1 vol/vol/vol phenol/chloroform/isoamyl alco-
hol) and chloroform/isoamylalcohol (24:1). After precip-
itation with 100% ethanol, the ssRNA was washed with
70% ethanol, and dissolved in 20 µl phosphate-buffered
saline (PBS). To produce dsRNA, equal nanogram
amounts of antisense and sense ssRNAs were mixed,
heated for five minutes at 95°C, and then slowly cooled
down to room temperature by switching off the heating
block. For quality control, 1 µl samples were taken after
each step and analyzed by gel electrophoresis. The dsRNA
was stored at -80°C until further use.
Ex ovo injection and electroporation
Injections and electroporations were performed at E8. The
embryos were staged according to Hamburger and Hamil-
ton [36]. To have direct access to the embryo, a small hole
of 3–4 mm diameter was cut into the extraembryonic
membranes above the eye. For positioning and stabiliza-
tion of the head during injection and subsequent electro-
poration, we used a hook prepared from a spatula (Figure
1a). Approximately 1 µl of the nucleic acid mixture con-
sisting of a plasmid encoding EGFP under the control of
the β-actin promoter (100 ng/µl), dsRNA derived from
AX-1 (500 ng/µl), and 0.04% (vol/vol) Trypan Blue (Inv-
itrogen, Carlsbad, CA, USA) dissolved in sterile PBS were
injected into the cerebellum using a borosilicate glass cap-
illary with a tip diameter of 5 µm (Figure 1a; World Preci-
sion Instruments, Berlin, Germany). Depending on the
depth of the injection, different cerebellar layers could be
targeted. To get transfection of all cerebellar layers, the
glass capillary was first inserted into the ventricular system
and injection pressure was maintained during retraction.
Before electroporation a few drops of sterile PBS were
added to the embryo. For the electroporation a platelet
electrode of 7 mm diameter (Tweezertrodes Model #520,
BTX Instrument Division, Harvard Apparatus, Holliston,Neural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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MA, USA) was placed collaterally to the head of the
embryo (Figure 1b). Six pulses of 40 V and 99 ms duration
with one second interpulse intervals were applied using a
square wave electroporator (ECM830, BTX). For the
present study, we selected only embryos that were success-
fully electroporated in the EGL and the developing ML for
further analysis. Slices and sections from experimental
embryos were compared with slices/sections taken from
the same position of a control cerebellum with respect to
both the anteroposterior and the mediolateral axis. As
controls we used CD34 dsRNA injected, EGFP plasmid
injected, and untreated control embryos, respectively.
For injections of function-blocking anti-AX-1 antibodies,
approximately 1 µl of the antibody solution (10 mg/ml
with 0.04% Trypan Blue in PBS) was injected into the cer-
ebellum three times every 12 h.
Tissue preparation
One to four days after electroporation the embryos were
sacrificed. The brain was removed and analyzed for EGFP
expression using a fluorescence stereomicroscope (SZX12,
Olympus). After fixation for 2 h at room temperature in
4% paraformaldehyde in PBS, the brain tissue was rinsed
in PBS and transferred to 25% sucrose in 0.1 M sodium
phosphate buffer, pH 7.4, for cryoprotection. In this
study, 30-µm-thick sagittal cryostat sections and 250-µm-
thick coronal vibratome slices were used. For the prepara-
tion of cryostat sections, the brains were embedded with
OCT Tissue-Tek in Peel-a-Way®  disposable embedding
molds (Polysciences, Eppelheim, Germany), frozen in
isopentane on dry ice, and cut on a cryostat (Leica
CM1850). The sections were collected on SuperFrost®Plus
microscope slides. For the preparation of 250-µm-thick
vibratome slices, the brain was embedded in 6.5% ultra
low-melting agarose (Type IX, Sigma, Buchs, Switzerland)
and cut with an OTS-300-04 oscillating tissue slicer (Elec-
tron Microscopy Sciences, Hatfield, PA, USA). The slices
were collected in PBS and the remaining agarose was
removed before staining.
Immunohistochemistry
Immunostaining of cryostat sections was done essentially
as described earlier [5]. We used the following primary
antibodies: rabbit anti-GFP (1:250; Abcam, Cambridge,
UK), FITC-labeled goat anti-GFP 1:400; Rockland, Gil-
bertsville, PA, USA), anti-Calbindin (1:1000; Swant, Bell-
inzona, Switzerland), both rabbit and goat anti-AX-1
(1:1,000) [3,25], goat anti-NgCAM, anti-NrCAM (both
1:1,000), rabbit anti-Contactin/F11 (1:1,000) [5], mouse
anti-neurofilament (RMO270; 1:1,500; Zymed/Invitro-
gen, Carlsbad, CA, USA), rabbit anti-neurofilament
(1:250; Chemicon/Millipore, Billerica, MA, USA), and the
monoclonal antibodies H5, recognizing Vimentin (super-
natant), and Pax6 (2 µg/ml; both obtained from the
Developmental Studies Hybridoma Bank, University of
Iowa, Iowa City, IA, USA). All antibodies were diluted in
blocking buffer (10% fetal calf serum in PBS). Incubation
was overnight at 4°C for primary antibodies and 90 min-
utes at room temperature for secondary antibodies. Sec-
ondary antibodies were: goat anti-rabbit-Alexa488 and
donkey anti-goat-Alexa488 (1:250; Molecular Probes/Inv-
itrogen), goat anti-mouse-Cy3 (1:250), donkey anti-rab-
bit-Cy3 (1:200), or donkey anti-goat-Cy3 (1:250; all
Jackson ImmunoResearch Laboratories, Newmarket, Suf-
folk, UK). For staining of vibratome slices, essentially the
same protocol was used, although incubation times were
extended [72]. Slices were mounted in sterile PBS between
two coverslips sealed with high vacuum grease (Dow
Corning, Wiesbaden, Germany).
Bromodeoxyuridine labeling
Embryos were injected with dsRNA derived from AX-1
and the EGFP plasmid, or with the EGFP plasmid alone,
and electroporated at HH34. After 4 days (HH38), 200 µl
50 mM bromodeoxyuridine (BrdU) in H2O were pipetted
onto the chorioallantois. After 3 h the embryos were sac-
rificed, and the brains were dissected and prepared for cry-
ostat sections as described above. For visualization of the
incorporated BrdU, the sections were incubated in 50%
formamide, 0.3 M NaCl in 0.03 M tri-sodium citrate
buffer, pH 7.0, for 1–2 h at 65°C, rinsed twice with 0.3 M
NaCl in 0.03 M tri-sodium citrate buffer for 15 minutes,
followed by incubation in 2 N HCl for 30 minutes at
37°C. Sections were rinsed in 0.1 M borate buffer (pH
8.5) for 10 minutes at room temperature, followed by PBS
(six changes). BrdU was detected using the mouse anti-
BrdU antibody from Sigma (1:200) using the protocol
detailed above. Sections were counterstained with DAPI
(5 µg/ml in PBS) for 20 minutes at room temperature.
TUNEL assay
Apoptosis was compared between embryos taken directly
from the egg, control embryos that were injected and elec-
troporated with the EGFP plasmid alone, or experimental
embryos injected with dsRNA derived from AX-1
(together with the EGFP plasmid). As a positive control,
sections were treated with DNase I (300 U/ml; Roche) for
10 minutes at room temperature. To detect apoptotic
cells, the ApoAlert DNA Fragmentation Assay Kit (Clon-
tech, Mountain View, CA, USA) was used according to the
manufacturer's instructions. The fragmented, fluorescein-
labeled DNA was detected with an alkaline phosphatase-
conjugated sheep anti-FITC antibody (1:1,000; Roche)
dissolved in 10% fetal calf serum/PBS. The alkaline phos-
phatase reaction was carried out as described earlier [73].
Quantification
Fluorescence intensities after AX-1 or neurofilament stain-
ing were measured with the analySIS Five software fromNeural Development 2008, 3:7 http://www.neuraldevelopment.com/content/3/1/7
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Olympus Soft Imaging System (Muenster, Germany). A
decrease of the protein level was calculated from the rela-
tive fluorescence intensities measured in the ML of the
transfected versus non-transfected areas. The staining
intensity was then compared between embryos injected
with dsRNA derived from AX-1, embryos injected with the
EGFP plasmid only, and untreated controls. For statistical
analyses ANOVA with Bonferroni correction was used.
Values are given as mean ± standard error of the mean. P-
values were < 0.0001.
In vitro assays
Granule cells were collected by microdissection of the cer-
ebellum at HH36. The EGL was separated from coronal
slices by cutting through the ML. The tissue was collected
in ice-cold HBSS (Hank's Balanced Salt Solution). After
trypsinization and trituration, cells were suspended in
MEM containing 10% fetal calf serum and penicilin/strep-
tomycin, and plated at a density of 50,000 cells per well of
an 8-well LabTek slide. Slides were coated with 20 µg/ml
laminin or 50 µg/ml AX-1 essentially as described in [44]
except that slides coated with laminin were precoated
with 100 µg/ml poly-lysine. After 48 h, cells were fixed in
4% paraformaldehyde for 1 h at room temperature. Cell
cultures contained granule cells and Bergmann glia cells
when coated on laminin as determined by Pax6 and GFAP
staining (not shown). On AX-1 substratum glia cells were
not able to spread. Neurite lengths were measured and are
representative for four different cultures. Antibodies were
added to the culture medium at a concentration of 5 µg/
ml.
In vitro electroporation
Granule cells suspended in culture medium (see above),
40 ng/µl EGFP plasmid, and 5 ng/µl dsRNA derived from
AX-1 were electroporated using the BTX Safety Stand 630B
and matching cuvettes connected to the BTX Electro
Square Porator ECM830. After electroporation with 1
pulse of 5 ms duration at 112 V cells were kept at 37°C for
5 minutes before plating. When cells were subject to elec-
troporation before culturing they were plated at a density
of 800,000 per well.
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